eH+, eHarmony Plus, GAME OVER now?
Forbidden new in the Online Dating Industry: eHarmony Brazil GAME OVER!
Forbidden new in the Online Dating Industry: Old data about eHarmony Japan big failure. Remember?
Forbidden new in the Online Dating Industry: Online Dating Spanish "war" in Mexico
Forbidden new in the Online Dating Industry: eHarmony Inc. - Affinitas GmbH. big war
Forbidden new in the Online Dating Industry: eDarling (Affinitas GmbH.) closed in Italy.
Forbidden new in the Online Dating Industry: CONFIRMED eDarling GAME OVER in Turkey!
Forbidden new in the Online Dating Industry: During 2012 eHarmony refused to acquire the whole of Affinitas GmbH. (eDarling and others, copycat of eHarmony) and went free/freemium in USA & CA
Mission accomplished. eHarmony ship will sink soon!
eHarmony is a 16 years old obsolete site and a HOAX, based on a big scientific fraud, only sustained by big marketing budget.
The Big Five normative test used by eHarmony, had been proven/revealed as an incomplete and incorrect model to assess/measure personality of persons.
Also ElevatedCareers by eHarmony WILL FAIL
The only way to revolutionize the Online Dating Industry is using the 16PF5 normative personality test, available in different languages to assess personality of members, or a proprietary test with exactly the same traits of the 16PF5 and expressing compatibility with eight decimals (needs a quantized pattern comparison method, part of pattern recognition by cross-correlation, to calculate similarity between prospective mates.)
High precision in matching algorithms is precisely the key to open the door and leave the infancy of compatibility testing.
Without offering the NORMATIVE 16PF5 (or similar test measuring exactly the 16 personality factors) for serious dating, it will be impossible to innovate and revolutionize the Online Dating Industry
The Online Dating Industry does not need a 10% improvement, a 50% improvement or a 100% improvement. It does need "a 100 times better improvement"
All other proposals are NOISE and perform as placebo.